Integral Diagnostics is forecast to grow earnings and revenue by 27.6% and 6.4% per annum respectively. EPS is expected to grow by 28.1% per annum. Return on equity is forecast to be 9.8% in 3 years.
Key information
27.6%
Earnings growth rate
28.15%
EPS growth rate
Healthcare earnings growth
19.8%
Revenue growth rate
6.4%
Future return on equity
9.76%
Analyst coverage
Good
Last updated
30 Jun 2026
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
OTCPK:ITGD.F - Analysts future estimates and past financials data (AUD Millions)
Date
Revenue
Earnings
Free Cash Flow
Cash from Op
Avg. No. Analysts
6/30/2029
977
72
76
159
3
6/30/2028
904
62
70
138
11
6/30/2027
853
53
68
131
12
6/30/2026
803
30
48
104
12
12/31/2025
768
14
27
85
N/A
9/30/2025
698
9
20
79
N/A
6/30/2025
627
5
14
74
N/A
3/31/2025
559
5
24
73
N/A
12/31/2024
491
6
34
73
N/A
9/30/2024
481
-28
38
70
N/A
6/30/2024
470
-61
42
66
N/A
3/31/2024
463
-59
29
62
N/A
12/31/2023
456
-58
16
58
N/A
9/30/2023
449
-16
20
63
N/A
6/30/2023
441
25
23
67
N/A
3/31/2023
418
23
20
56
N/A
12/31/2022
395
21
17
45
N/A
9/30/2022
378
18
13
41
N/A
6/30/2022
361
15
9
37
N/A
3/31/2022
361
18
14
41
N/A
12/31/2021
360
22
18
44
N/A
9/30/2021
356
26
34
57
N/A
6/30/2021
351
31
49
70
N/A
3/31/2021
333
32
54
73
N/A
12/31/2020
315
32
59
76
N/A
9/30/2020
295
28
44
65
N/A
6/30/2020
276
23
28
54
N/A
3/31/2020
263
22
19
47
N/A
12/31/2019
250
21
9
39
N/A
9/30/2019
241
21
N/A
37
N/A
6/30/2019
232
21
N/A
34
N/A
3/31/2019
222
19
N/A
30
N/A
12/31/2018
211
17
N/A
26
N/A
9/30/2018
200
16
N/A
26
N/A
6/30/2018
189
15
N/A
27
N/A
3/31/2018
187
15
N/A
27
N/A
12/31/2017
185
15
N/A
27
N/A
9/30/2017
182
15
N/A
25
N/A
6/30/2017
180
15
N/A
23
N/A
3/31/2017
177
16
N/A
26
N/A
12/31/2016
175
16
N/A
30
N/A
9/30/2016
171
14
N/A
27
N/A
6/30/2016
168
11
N/A
24
N/A
3/31/2016
165
11
N/A
22
N/A
12/31/2015
162
11
N/A
20
N/A
9/30/2015
157
8
N/A
18
N/A
Analyst Future Growth Forecasts
Earnings vs Savings Rate: ITGD.F's forecast earnings growth (27.6% per year) is above the savings rate (3.5%).
Earnings vs Market: ITGD.F's earnings (27.6% per year) are forecast to grow faster than the US market (18.4% per year).
High Growth Earnings: ITGD.F's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: ITGD.F's revenue (6.4% per year) is forecast to grow slower than the US market (12.7% per year).
High Growth Revenue: ITGD.F's revenue (6.4% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: ITGD.F's Return on Equity is forecast to be low in 3 years time (9.8%).
Discover growth companies
7D
1Y
7D
1Y
7D
1Y
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2026/07/07 20:48
End of Day Share Price
2026/07/02 00:00
Earnings
2025/12/31
Annual Earnings
2025/06/30
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Integral Diagnostics Limited is covered by 22 analysts. 13 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.